Abstracts tagged "Work Disability and vasculitis"

Abstract Number: 2076 • 2016 ACR/ARHP Annual Meeting
Impact of Vasculitis on Employment and Income: An Online Survey of Participants in the Rare Diseases Clinical Research Network – Vasculitis Clinical Research Consortium Patient Contact Registry
Lillian Barra¹, Renee Borchin², Cristina Burroughs³, Simon Carette⁴, George Casey⁵, Carol A McAlear⁶, Antoine Sreih⁷, Kalen Young⁵, Peter A. Merkel⁸, Christian Pagnoux⁹ and Vasculitis Clinical Research Consortium and the Vasculitis Patient-Powered Research Network , ¹Medicine, Division of Rheumatology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, ²University of South Florida, Tampa, FL, ³Vasculitis center, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ⁴Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ⁵Vasculitis Foundation, Kansas city, MN, ⁶Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ⁷Department of Rheumatology, University of Pennsylvania, Philadelphia, PA, ⁸Division of Rheumatology, Univ of Pennsylvania; Perelman School of Med, Philadelphia, PA, ⁹Division of Rheumatology, Mount Sinai Hospital, University Health Network, University of Toronto, Toronto, Canada, Toronto, ON, Canada
Background/Purpose: Work disability associated with rheumatic diseases accounts for an important part of the costs of these conditions. Few studies have investigated disability among patients…
Abstract Number: 1759 • 2014 ACR/ARHP Annual Meeting
Analysis of Employment, Work Disability and Quality of Life of Patients with ANCA-Associated Vasculitis
Lucas Benarous¹, Benjamin Terrier², Alice Berezne³, Bertrand Dunogué⁴, Hervé Laborde-Casterot⁵, Pascal Cohen⁶, Xavier Puéchal⁶, Nathalie Costedoat-Chalumeau⁷, Claire Le Jeunne⁶, Dominique Choudat⁵, Luc Mouthon⁶ and Loïc Guillevin for the French Vasculitis Study Group⁶, ¹Cochin Hospital, Paris, France, ²National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, ³Paris Descartes University, Internal Medicine department, Cochin Hospital, Paris, France, ⁴Internal Medicine, Hôpital Cochin, Paris, France, ⁵Médecine du Travail, Cochin Hospital, Paris, France, ⁶National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, ⁷Internal medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France
Background/Purpose Improved therapeutic strategies for ANCA-associated vasculitis (AAV) have transformed acute and life-threatening diseases into chronic ones responsible for marked morbidity that could impact employment,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].